Markets a biomarker diagnostic test for heart failure and is developing others.
Industry: Health Care
First Day Return: +15.0%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 01/29/2010 |
Offer Price | $7.00 |
Price Range $13.00 - $15.00 | |
Offer Shares (mm) | 5.0 |
Deal Size ($mm) | $35 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 02/03/2011 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $35 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Waltham, MA, United States |
Founded | 2000 |
Employees at IPO | 51 |
Website www.bg-medicine.com |